Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) FCF Margin (2020 - 2025)

Historic FCF Margin for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to 7.1%.

  • NeuroPace's FCF Margin rose 17900.0% to 7.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.43%, marking a year-over-year increase of 45400.0%. This contributed to the annual value of 22.85% for FY2024, which is 75300.0% up from last year.
  • Per NeuroPace's latest filing, its FCF Margin stood at 7.1% for Q3 2025, which was up 17900.0% from 9.2% recorded in Q2 2025.
  • In the past 5 years, NeuroPace's FCF Margin ranged from a high of 7.1% in Q3 2025 and a low of 106.51% during Q2 2022
  • In the last 5 years, NeuroPace's FCF Margin had a median value of 42.11% in 2024 and averaged 43.53%.
  • In the last 5 years, NeuroPace's FCF Margin crashed by -583600bps in 2022 and then surged by 798600bps in 2023.
  • Over the past 5 years, NeuroPace's FCF Margin (Quarter) stood at 75.97% in 2021, then increased by 18bps to 62.37% in 2022, then soared by 70bps to 18.5% in 2023, then fell by -21bps to 22.31% in 2024, then skyrocketed by 68bps to 7.1% in 2025.
  • Its FCF Margin was 7.1% in Q3 2025, compared to 9.2% in Q2 2025 and 33.92% in Q1 2025.